Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation
Dal 2006-01-01
al 2011-06-30
Dettagli del progetto
Costo totale:
EUR 12 000 001Contributo UE:
EUR 12 000 000Coordinato in:
SwedenArgomento (i):
LSH-2004-1.1.5-1 - Unravelling the mechanisms and functions of post-translational modifications of proteinsInvito a presentare proposte:
FP6-2004-LIFESCIHEALTH-5See other projects for this callMeccanismo di finanziamento:
NoE - Network of ExcellenceObiettivo
Coordinatore
KAROLINSKA INSTITUTET
Sweden
Partecipanti
THE NETHERLANDS CANCER INSTITUTE/ANTONI VAN LEEUWENHOEK HOSPITAL
Netherlands
UNIVERSITY MEDICAL CENTER
Netherlands
Heidelberglaan 100
85500 UTRECHT
Netherlands
85500 UTRECHT
Netherlands
MEDICAL RESEARCH COUNCIL
United Kingdom
UNIVERSITY OF DUNDEE
United Kingdom
INSTITUT PASTEUR
France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
France
MAX PLANCK SOCIETY FOR THE ADVANCEMENT OF SCIENCE
Germany
BEREICH HUMANMEDIZIN DER GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS -
Germany
MAX-DELBRUECK-CENTRUM FUER MOLEKULARE MEDIZIN
Germany
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE
Italy
TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY
Israel
Technion City, Neve Sha'anan
HAIFA
Israel
See on map
HAIFA
Israel
See on map
Contatto amministrativo: Aaron CIECHANOVER
Tel.: +972-48295356
Fax: +972-48513922
Tel.: +972-48295356
Fax: +972-48513922
THE HEBREW UNIVERSITY OF JERUSALEM
Israel
The Authority for Research and Development, Edmond J. Safra Campus, Givat Ram
JERUSALEM
Israel
JERUSALEM
Israel
PEPSCAN SYSTEMS B.V.
Netherlands
Zuidersluisweg 2
2098 LELYSTAD
Netherlands
2098 LELYSTAD
Netherlands
DRUG DISCOVERY FACTORY BV
Netherlands
PROTEOLOGICS LTD
Israel
PEPSCAN THERAPEUTICS BV
Netherlands
ENZO LIFE SCIENCES LTD
United Kingdom
RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Germany
SA CYTOMICS PHARMACEUTICALS
France
UNIVERSITÄT KONSTANZ
Germany
UNIVERSITÄT STUTTGART
Germany
UNIVERSITÄT ZU KÖLN
Germany